Opioid receptor agonists and antagonists alter GBR12909-induced turning in the rat

European Journal of Pharmacology

Volumn 343, Issue 2-3, 1998, Pages 119-127

  Kimmel, Heather L ^a   Holtzman, Stephen G ^a  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

GBR12909; Morphine; Naloxone; NaltrexoneNigrostriatal lesion; Rotational behavior

Indexed keywords

BETA FUNALTREXAMINE; COCAINE; DOPAMINE UPTAKE INHIBITOR; FLUOXETINE; METHADONE; MORPHINE; MU OPIATE RECEPTOR AGONIST; NALOXONE; NALTREXONE; NALTRINDOLE; NISOXETINE; NORADRENALIN UPTAKE INHIBITOR; NORBINALTORPHIMINE; OPIATE AGONIST; OPIATE ANTAGONIST; SEROTONIN UPTAKE INHIBITOR; VANOXERINE;

ANIMAL EXPERIMENT; ARTICLE; BRAIN INJURY; CIRCLING BEHAVIOR; CONTROLLED STUDY; DRUG ANTAGONISM; DRUG POTENTIATION; INTRACISTERNAL DRUG ADMINISTRATION; INTRAPERITONEAL DRUG ADMINISTRATION; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; SUBCUTANEOUS DRUG ADMINISTRATION; SUBSTANTIA NIGRA;

ANIMALS; DOPAMINE UPTAKE INHIBITORS; DOSE-RESPONSE RELATIONSHIP, DRUG; MALE; METHADONE; MORPHINE; MOTOR ACTIVITY; NALOXONE; PIPERAZINES; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, OPIOID;

EID: 0032545917     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0014-2999(97)01532-X     Document Type: Article

References (27)

1. Anderson P.H. The dopamine uptake inhibitor GBR12909: Selectivity and molecular mechanism of action. Eur. J. Pharmacol. 166:1989;493-504.
2. Baumann M.H., Char G.U., DeCosta B.R., Rice K.C., Rothman R.B. GBR 12909 attenuates cocaine-induced activation of mesolimbic dopamine neurons in the rat. J. Pharmacol. Exp. Ther. 271:1994;1216-1222.
3. Callaway C.W., Wing L.L., Geyer M.A. Serotonin release contributes to the locomotor stimulant effects of 3,4-methylenedioxymethamphetamine in rats. J. Pharmacol. Exp. Ther. 254:1990;456-464.
4. Gifford A.N., Bergmann J.S., Johnson K.M. GBR12909 fails to antagonize cocaine-induced elevation of dopamine in striatal slices. Drug Alcohol Depend. 32:1993;65-71.
5. Heikkila R.E., Manzino L. Behavioral properties of GBR12909, GBR13069, GBR12098: Specific inhibitors of dopamine uptake. Eur. J. Pharmacol. 103:1984;241-248.
6. Horowitz J.M., Kristal M.B., Torres G. Differential behavioral response to cocaethylene of Long-Evans and Sprague-Dawley rats: Role of serotonin. Synapse. 26:1997;11-21.
7. Hudson J.L., van Horne C.G., Stromberg I., Brock S., Clayton J., Masserano J., Hoffer B.J., Gerhardt G.A. Correlation of apomorphine- and amphetamine-induced turning with nigrostriatal dopamine content in unilateral 6-hydroxydopamine lesioned rats. Br. Res. 626:1993;167-174.
8. Kalivas P.W., Stewart J. Dopamine transmission in the initiation and expression of drug- and stress-induced sensitization of motor activity. Br. Res. Rev. 16:1991;223-244.
9. Kelley A.E., Lang C.G. Effects of GBR12909, a selective dopamine uptake inhibitor, on motor activity and operant behavior in the rat. Eur. J. Pharmacol. 167:1989;385-395.
10. Kimmel H.L., Holtzman S.G. Mu-opioid agonists potentiate amphetamine- and cocaine-induced rotational behavior in the rat. J. Pharmacol. Exp. Ther. 282:1997;734-746.
11. Kimmel H.L., Tallarida R.J., Holtzman S.G. Synergism between buprenorphine and cocaine on the rotational behavior of the nigrally-lesioned rat. Psychopharmacology. 133:1997;372-377.
12. Kleven M.S., Anthony E.W., Woolverton W.L. Pharmacological characterization of the discriminative stimulus effects of cocaine in rhesus monkeys. J. Pharmacol. Exp. Ther. 254:1990;312-317.
13. Mansour A., Fox C.A., Akil H., Watson S.J. Opioid-receptor mRNA expression in the rat CNS: Anatomical and functional implications. Trends Neurosci. 18:1995;22-29.
14. Nakachi N., Kiuchi Y., Inagaki M., Inazu M., Yamazaki Y., Oguchi K. Effects of various dopamine uptake inhibitors on striatal extracellular dopamine levels and behaviours in rats. Eur. J. Pharmacol. 281:1995;195-203.
15. Paronis C.A., Waddell A.B., Holtzman S.G. Naltrexone in vivo protects μ receptors from inactivation by β-funaltrexamine, but not κ receptors from inactivation from nor-binaltorphimine. Pharmacol. Biochem. Behav. 46:1993;813-817.
16. Patterson, A.B., Holtzman, S.G., 1997. Naltrindole a selective δ-opioid receptor antagonist, potentiates the lethal effects of cocaine by a central mechanism of action. Eur. J. Pharmacol.
17. Paxinos, G., Watson, C., 1986. The Rat Brain in Stereotaxic Coordinates. Academic Press, Sydney.
18. Rempel N.L., Callaway C.W., Geyer M.A. Serotonin1B receptor activation mimics behavioral effects of presynaptic serotonin release. Neuropsychopharmacology. 8:1993;201-211.
19. Robinson T.E., Becker J.B. The rotational behavior model: Asymmetry in the effects of unilateral 6-OHDA lesions of the substantia nigra in rats. Br. Res. 264:1983;127-131.
20. Rothman R.B., Mele A., Reid A.A., Akunne H., Greig N., Thurkauf A., Rice K.C., Pert A. Tight binding dopamine reuptake inhibitors as cocaine antagonists. A strategy for drug development. FEBS Lett. 257:1989;341-344.
21. Rothman R.B., Mele A., Reid A.A., Akunne H.C., Greig N., Thurkauf A., de Costa B.R., Rice K.C., Pert A. GBR12909 antagonizes the ability of cocaine to elevate extracellular levels of dopamine. Pharmacol. Biochem. Behav. 40:1991;387-397.
22. Schad C.A., Justice J.B. Jr., Holtzman S.G. Differential effects of δ- and μ-opioid receptor antagonists on the amphetamine-induced increase in extracellular dopamine in striatum and nucleus accumbens. J. Neurochem. 67:1996;2292-2299.
23. Shaham Y., Rajabi H., Stewart J. Relapse to heroin-seeking in rats under opioid maintenance: The effects of stress, heroin priming, and withdrawal. J. Neurosci. 16:1996;1957-1963.
24. Tyler T.D., Tessel R.E. Norepinephrine uptake inhibitors as biochemically and behaviorally selective antagonists of the locomotor stimulation induced by indirectly acting sympathomimetic amines in mice. Psychopharmacology. 69:1980;27-34.
25. Ungerstedt U., Arbuthnott G.W. Quantitative recording of rotational behavior in rats after 6-hydroxydopamine lesions of the nigrostriatal dopamine behaviour system. Br. Res. 24:1970;485-493.
26. Van der Zee P., Koger H.S., Gootjes J., Hespe W. Aryl 1,4-dialk(en)ylpiperazines as selective and very potent inhibitors of dopamine uptake. Eur. J. Med. Chem. 15:1980;363-370.
27. Wood P.L., Charleson S.E., Lane D., Hudgin R.L. Multiple opiate receptors: Differential binding of μ, κ and δ agonists. Neuropharmacology. 20:1981;1215-1220.